Quick Quiz

Approximately 3.4 million Americans will be diagnosed with skin cancer in 2022, making it the most common form of cancer in the United States. Included in this estimation are patients with basal-cell carcinoma and squamous-cell carcinoma, which are the most common types of skin cancer, as well as patients with melanoma, which accounts for approximately 1% of all skin cancers, but is responsible for a large majority of skin cancer–related deaths. Although the total number and incidence rates of basal-cell carcinoma and squamous-cell carcinoma cannot be precisely determined because reporting to cancer registries is not required, it is estimated that they account for less than 0.1% of patient deaths caused by cancer. However, the American Cancer Society estimates that approximately 99,780 individuals will be diagnosed with melanoma in 2022, and approximately 7650 individuals will die from the disease. How much do you know about skin cancer?

Soft tissue sarcoma is a rare form of cancer that begins in tissues that connect or support other structures in the body, such as fat, muscle, nerves, fibrous tissues, blood vessels, or deep skin tissues. Although the majority of soft tissue sarcomas originate in the arms or legs, they can also be found in internal organs or the retroperitoneum, the trunk, or the head and neck area. Soft tissue sarcomas are most commonly diagnosed in children, accounting for approximately 15% of all pediatric cancers. According to the American Cancer Society, approximately 13,190 individuals (7590 men and 5600 women) will be diagnosed with soft tissue sarcomas in the United States in 2022, and approximately 5130 individuals (2740 men and 2390 women) will die from the disease. How much do you know about soft tissue sarcomas?

On June 5, 2022, people around the world will celebrate National Cancer Survivors Day^®, a time set aside to recognize cancer survivors, raise awareness of the ongoing challenges these individuals face because of their disease, and celebrate life. A cancer survivor can be defined as anyone who has a history of cancer, from diagnosis through treatment and the remainder of life. The American Cancer Society, the National Cancer Institute, and many other organizations focus a great deal of their efforts on helping cancer survivors manage any ongoing physical, psychosocial, and functional problems related to their disease and treatments, and promoting cancer survivor health and quality of life. How much do you know about cancer survivorship?

Brain and spinal cord tumors are rare forms of cancer, accounting for approximately 1.3% of all new cancer cases in the United States. The lifetime risk for being diagnosed with a malignant tumor of the brain or spinal cord is <1%. According to the American Cancer Society, approximately 25,050 individuals (14,170 men and 10,880 women) will be diagnosed with malignant tumors of the brain or spinal cord in 2022, and approximately 18,280 individuals (10,170 men and 7570 women) will die from the disease. The overall 5-year survival rate for brain and spinal cord tumors is approximately 36%; 75% for individuals aged <15 years; 72% for individuals aged 15 to 39 years; and 21% for individuals aged >40 years. How much do you know about brain and spinal cord tumors?

Testicular cancer is a malignancy that most commonly originates in the germ cells of 1 or both of the testicles. Although rare, testicular cancer is one of the most frequently diagnosed cancers in young adult men between the ages of 30 and 39 years. For reasons that have yet to be identified, the incidence rates for testicular cancer has been on the rise for the past several decades, although this increase in rates has slowed in recent years. According to the American Cancer Society, approximately 9910 men in the United States will be diagnosed with testicular cancer in 2022, and approximately 460 will die from the disease. How much do you know about testicular cancer?

Kidney cancer, also known as renal cancer, is one of the top 10 most common cancers in both men and women in the United States. According to the American Cancer Society, approximately 79,000 individuals (50,290 men and 28,710 women) will be diagnosed with kidney cancer in 2022, and approximately 13,920 individuals (8960 men and 4960 women) will die from the disease. Kidney cancer is most frequently diagnosed in individuals aged 65 to 74 years, and is uncommon in those younger than 45 years. The incidence of kidney cancer has been increasing for several decades, although this uptick in cases has slowed in recent years. Although experts are not certain what is causing this rise in incidence, many believe that is can be attributed in part to the use more effective scanning techniques, which can detect the disease at an earlier stage. How much do you know about kidney cancer?

Bladder cancer is the sixth most common cancer diagnosed in the United States. It is the fourth most common cancer in men and the twelfth most common cancer in women. According to the American Cancer Society, approximately 81,180 new cases of bladder cancer (61,700 men and 19,480 women) will be diagnosed in the United States in 2022, and approximately 17,100 individuals (12,120 men and 4980 women) will die from the disease. How much do you know about bladder cancer?

Myelodysplastic syndromes (MDS) are a group of diverse disorders in which the bone marrow does not produce enough healthy blood cells. Although it is primarily a disease of the elderly, MDS can affect younger patients as well. The number of individuals diagnosed with MDS in the United States each year is not known for sure, but estimates range from approximately 10,000 to 30,000-55,000. The incidence rate of MDS appears to be on the rise, which may be due to improvements in recognition and criteria for the diagnosis of the disease, as well as an increase in the aging population. How much do you know about MDS?

Gastric cancer is a relatively rare malignancy in the United States, representing 1.5% of all new cancer cases and 1.8% of all cancer deaths. The American Cancer Society estimates that in 2021, approximately 26,560 individuals (16,160 men and 10,400 women) will be diagnosed with gastric cancer, and approximately 11,180 individuals (6740 men and 4440 women) will die from the disease. The number of new cases of gastric cancer has been declining by approximately 1.5% annually over the past 10 years in the United States. How much do you know about gastric cancer?

Pancreatic cancer is a relatively rare malignancy, representing 3.2% of all new cancer cases in the United States. In 2021, it is estimated that approximately 60,430 individuals (31,950 men and 28,480 women) will be diagnosed with pancreatic cancer in this country, and approximately 48,220 individuals (25,270 men and 22,950 women) will die from the disease. The average lifetime risk for being diagnosed with pancreatic cancer is 1 in 64, and incidence rates for the disease have increased by approximately 1% each year since 2000. How much do you know about pancreatic cancer?